Overview

Assessment of Multi-Modality Quantitative Imaging for Evaluation of Response of Metastatic Prostate Cancer to Therapy

Status:
Recruiting
Trial end date:
2023-08-15
Target enrollment:
Participant gender:
Summary
The study is an open label, non-randomized study designed to evaluate the diagnostic performance of SPECT CT.
Phase:
Phase 1
Details
Lead Sponsor:
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Collaborator:
National Cancer Institute (NCI)